Aix, S. P., Navarro, A., Garcia, M. E. O., Mezquita, L., Majem, M., Vicente, D., Bernabé, R., Pellitero, A. M., Cobo, M., Castro, J. D., Ros, S., Brea, M. L., Campelo, R. G., Baena, J., Bote, H., Herrera, M., Rocha, P., Zugazagoitia, J., Felip, E., Paz-Ares, L. G. (2025). Safety and efficacy of lurbinectedin plus atezolizumab as second-line treatment for advanced small-cell lung cancer: Results of the 2SMALL phase 1/2 study (NCT04253145).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8013